NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/21/2026
Back to search
Official data from USPTO
ADJUVIA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
04/21/2026
Trademark type
Combined
Nice classes
42
Filing date
07/02/2025
Registration date
04/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2023-05-00
First use in commerce
2023-05-00
Drawing code
3
Owner type
03
Owner location
San Francisco, CA, US
Examiner
SMITH, BRENDAN K
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a depiction of an algae plant next to the words "ADJUVIA THERAPEUTICS" in stylized font where "ADJUVIA" is above the word "THERAPEUTICS".
Holders and representatives
Holders
Adjuvia Therapeutics, Inc.
Representatives
James Klobucar Gearhart Law
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals and therapeutics in the field of rare and chronic diseases that arise from mitochondrial and cellular dysfunction; Pharmaceutical and therapeutics products research and development; pharmaceutical drugs development research
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2026
PUBO
PUBLISHED FOR OPPOSITION
03/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/21/2025
GNRT
NON-FINAL ACTION E-MAILED
11/21/2025
CNRT
NON-FINAL ACTION WRITTEN
11/21/2025
DOCK
ASSIGNED TO EXAMINER
11/20/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/07/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/02/2025
NWAP
NEW APPLICATION ENTERED
07/02/2025
Continuous trademark protection
Get notified about every new filing that threatens ADJUVIA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.